• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy" [Int. Immunopharmacol. 121 (2023) 110465].

作者信息

Xia Jing, He Siyue, Dai Qianlong, Jia Huijie, Ge Yuchen, Zhou Min, Wang Xiao-Bo

机构信息

School of Basic Medicine, Dali University, Dali, Yunnan 671000, China; Key Laboratory of University Cell Biology Yunnan Province, Dali, Yunnan 671000, China.

School of Basic Medicine, Dali University, Dali, Yunnan 671000, China; Key Laboratory of University Cell Biology Yunnan Province, Dali, Yunnan 671000, China.

出版信息

Int Immunopharmacol. 2023 Aug;121:110620. doi: 10.1016/j.intimp.2023.110620. Epub 2023 Jul 15.

DOI:10.1016/j.intimp.2023.110620
PMID:37455170
Abstract
摘要

相似文献

1
Corrigendum to "Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy" [Int. Immunopharmacol. 121 (2023) 110465].
Int Immunopharmacol. 2023 Aug;121:110620. doi: 10.1016/j.intimp.2023.110620. Epub 2023 Jul 15.
2
Corrigendum to "Liproxstatin-1 alleviates LPS/IL-13-induced bronchial epithelial cell injury and neutrophilic asthma in mice by inhibiting ferroptosis" [Int. Immunopharmacol. 109 (2022) 108770].《Liproxstatin-1通过抑制铁死亡减轻LPS/IL-13诱导的小鼠支气管上皮细胞损伤和嗜中性粒细胞性哮喘》的勘误[《国际免疫药理学》109卷（2022年）108770页]
Int Immunopharmacol. 2023 Feb;115:109482. doi: 10.1016/j.intimp.2022.109482. Epub 2023 Jan 6.
3
Corrigendum to "Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM/ceramide pathway" [Int. Immunopharmacol. 133 (2024) 112083].
Int Immunopharmacol. 2024 Jun 15;134:112270. doi: 10.1016/j.intimp.2024.112270. Epub 2024 May 18.
4
Corrigendum to "RNF125, transcriptionally regulated by NFATC2, alleviates osteoarthritis via inhibiting the Wnt/β-catenin signaling pathway through degrading TRIM14" [Int. Immunopharmacol. 125 (2023) 111191].
Int Immunopharmacol. 2024 Jan 25;127:111425. doi: 10.1016/j.intimp.2023.111425. Epub 2023 Dec 23.
5
Corrigendum to "Sodium houttuyfonate enhances the intestinal barrier and attenuates inflammation induced by Salmonella typhimurium through the NF-κB pathway in mice" [Int. Immunopharmacol. 89 (2020) 107058].《鱼腥草素钠增强小鼠肠道屏障并通过NF-κB途径减轻鼠伤寒沙门氏菌诱导的炎症》[《国际免疫药理学》89卷（2020年）107058页]的勘误
Int Immunopharmacol. 2021 Mar;92:107351. doi: 10.1016/j.intimp.2020.107351. Epub 2021 Jan 11.
6
Corrigendum to "Leukotriene D4 induces cellular senescence in osteoblasts" [Int. Immunopharmacol. 58 (2018)154-159].《白三烯 D4 诱导成骨细胞衰老》[《国际免疫药理学》58(2018)154 - 159]的勘误
Int Immunopharmacol. 2024 Mar 10;129:111673. doi: 10.1016/j.intimp.2024.111673. Epub 2024 Feb 16.
7
Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].
Int Immunopharmacol. 2023 Sep;122:110699. doi: 10.1016/j.intimp.2023.110699. Epub 2023 Jul 26.
8
Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005].《硝普钠通过减轻氧化应激、炎症和细胞凋亡缓解乙酸诱导的大鼠结肠炎》的勘误 [《国际免疫药理学》99卷（2021年）108005页]
Int Immunopharmacol. 2022 Apr;105:108575. doi: 10.1016/j.intimp.2022.108575. Epub 2022 Feb 1.
9
Corrigendum to "Oleamide suppresses inflammatory responses in LPS-induced RAW264.7 murine macrophages and alleviates paw edema in a carrageenan-induced inflammatory rat model" [Int. Immunopharmacol. 56 (2018) 179-185].《油酸酰胺抑制脂多糖诱导的RAW264.7小鼠巨噬细胞炎症反应并减轻角叉菜胶诱导的炎症大鼠模型中的爪肿胀》的勘误[《国际免疫药理学》56卷（2018年）第179 - 185页]
Int Immunopharmacol. 2018 Jul;60:246. doi: 10.1016/j.intimp.2018.05.006. Epub 2018 May 19.
10
Corrigendum to "Pmepa1 knockdown alleviates SpA-induced pyroptosis and osteogenic differentiation inhibition of hBMSCs via p38MAPK/NLRP3 axis" [Int. Immunopharmacol. 124(Part A) (2023) 110843].《“Pmepa1基因敲低通过p38丝裂原活化蛋白激酶/核苷酸结合寡聚化结构域样受体蛋白3轴减轻脊柱关节炎诱导的人骨髓间充质干细胞焦亡和成骨分化抑制”的勘误》[《国际免疫药理学》124(Part A)(2023)110843]
Int Immunopharmacol. 2023 Nov;124(Pt A):111013. doi: 10.1016/j.intimp.2023.111013. Epub 2023 Oct 6.